2006 report, Medicines in development, biotechnology. PhRMA Website. 2006; Available at: http://www.phrma.org/files/Biotech%202006.pdf. Accessed January 14, 2007.
Findlay JWA, Smith WC, Lee JW, et al. Validation of immunoassays for bioanalysis: a pharmaceutical industry perspective.J Pharm Biomed Anal. 2000;21:1249–1273.
PubMed
Article
CAS
Google Scholar
DeSilva B, Smith W, Weiner R, et al. Recommendations for the bioanalytical method validation of ligand-binding assays to support pharmacokinetic assessments of macromolecules.Pharm Res. 2003;20:1885–1900.
PubMed
Article
CAS
Google Scholar
Shah VP, Midha KK, Dighe S, et al. Analytical methods validation: bioavailability, bioequivalence and pharmacokinetic studies.Pharm Res. 1992;9:588–592.
Article
Google Scholar
Miller KJ, Bowsher RR, Celniker A, et al. Workshop on bioanalytical methods validation for macromolecules: summary report.Pharm Res. 2001;18:1373–1383.
PubMed
Article
CAS
Google Scholar
Shah VP, Midha KK, Findlay JWA, et al. Bioanalytical method validation—a revisit with a decade of progress.Pharm Res. 2000;17:1551–1557.
PubMed
Article
CAS
Google Scholar
Vishwanathan CT Bansal S, Booth B, et al. Quantitative bioanalytical methods validation and implementation best practices for chromatographic and ligand binding assays.AAPS J [serial online]. 2007;9:E30-E42.
Article
Google Scholar
Food and Drug Administration.Guidance for Industry: Bioanalytical. Method Validation. Rockville, MD: US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research; 2001.
Google Scholar
Rodbard D, Frazier GR. Statistical analysis of radioligand assay data.Methods Enzymol. 1975;37:3–22.
PubMed
Google Scholar
Haven MC, Orsulak PJ, Arnold LL, et al. Data-reduction methods for immunoradiometric assays of thyrotropin compared.Clin Chem. 1987;33:1207–1210.
PubMed
CAS
Google Scholar
Dudley RA, Edwards P, Ekins RP, et al. Guidelines for immunoassay data processing.Clin Chem. 1985;31:1264–1271.
PubMed
CAS
Google Scholar
Gottschalk PG, Dunn JR. The five-parameter logistic: a characterization and comparison with the four-parameter logistic.Anal Biochem. 2005;343:54–65.
PubMed
CAS
Article
Google Scholar
Box GEP, Hunter WG, Hunter JS, eds.Statistics for Experimenters. New York, NY: John Wiley & Sons: 1978.
Google Scholar
Finney DJ, Phillips P. The form and estimation of a variance function, with particular reference to radioimmunoassay.Appl Stat. 1977;26:312–320.
Article
Google Scholar
Finney DJ, ed.Statistical Methods in Biological Assay. 3rd ed. London, UK: Charles Griffith; 1978.
Google Scholar
Carroll RJ, Ruppert D, eds.Transformation and Weighting in Regression. London, UK: Chapman Hall; 1988.
Google Scholar
Rocke DM, Jones G. Optimal design for ELISA and other forms of immunoassay.Technometrics. 1997;39:162–170.
Article
Google Scholar
Karpinski KF. Optimality assessment in the enzyme-linked immunosorbent assay (ELISA).Biometrics. 1990;46:381–390.
PubMed
Article
CAS
Google Scholar
Singer R, Lansky DM, Hauck WW. Bioassay glossary.Pharmacopeial Forum. 2006;32:1359–1365.
Google Scholar
Karnes HT, March C. Calibration and validation of linearity in chromatographic biopharmaceutical analysis.J Pharm Biomed Anal. 1991;9:911–918.
PubMed
Article
CAS
Google Scholar
Smith WC, Sittampalam GS. Conceptual and statistical issues in the validation of analytic dilution assays for pharmaceutical applications.J Biopharm Stat. 1998;8:509–532.
PubMed
Article
CAS
Google Scholar